EDCTP aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat HIV/AIDS, tuberculosis, malaria and other poverty-related infectious diseases, including neglected infectious diseases and emerging or re-emerging infectious diseases, prevalent in sub-Saharan Africa.
EDCTP’s second programme (2014-2024) supports all clinical trial phases (I-IV) including health services optimisation research. Research and regulatory capacity development remain integrated in the research funding strategy in order to strengthen the conditions for conducting clinical research in sub-Saharan Africa.
The EDCTP programme will be executed through partnerships between European and African institutions and researchers in collaboration with the pharmaceutical industry and like-minded organisations.
The programme is implemented as part of the European Framework Programme for Research and Innovation, Horizon 2020 and governed by the participating African and European countries.
Strategy and implementation
EDCTP strategy is guided and implemented according to the following documents.